um with this growth, I'm pretty sure we're gonna be seeing some offers imminently
Sentiment: Strong Buy
no way Roche allows illumina to buy PACB when they lost acquiring ILMN - PACB goes to Roche and everyone benefits
if they IPO'd at $18 and will release a new instrument, this stock will be right around there in no time
Announcement imminent - desktop sequencer with NEGLIGIBLE CONSUMABLES and longest read lengths in the industry. Acquisition by Roche?
We were told this when Roche tried the hostile takeover at $60.
They just need better sample prep to automate and standardize sample processing which is still a huge source of variability in the experiments I have seen/performed.
if FLDM bought PACB, they could finally give ILMN a run for their $